These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 45724)

  • 21. Uptake of radiolabelled herceptin by experimental mammary adenocarcinoma.
    Wiercioch R; Balcerczak E; Byszewska E; Mirowski M
    Nucl Med Rev Cent East Eur; 2003; 6(2):99-103. PubMed ID: 14737722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of some 14-O-acyl derivatives of adriamycin.
    Arcamone F; Franceschi G; Minghetti A; Penco S; Redaelli S
    J Med Chem; 1974 Mar; 17(3):335-7. PubMed ID: 4811230
    [No Abstract]   [Full Text] [Related]  

  • 23. Rate of nucleic acid synthesis in mammary hyperplastic alveolar nodule outgrowths and transplanted adenocarcinomas in pregnant and lactating mice.
    Bartley JC; Barber S; Abraham S
    Cancer Res; 1974 Oct; 34(10):2571-5. PubMed ID: 4415478
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain.
    Upadhyay UM; Tyler B; Patta Y; Wicks R; Spencer K; Scott A; Masi B; Hwang L; Grossman R; Cima M; Brem H; Langer R
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16071-6. PubMed ID: 25349381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9).
    Cutts SM; Rephaeli A; Nudelman A; Hmelnitsky I; Phillips DR
    Cancer Res; 2001 Nov; 61(22):8194-202. PubMed ID: 11719450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic model describing the growth of a mammary carcinoma in the mouse under the influence of adriamycin treatment.
    Dagnino G; Donelli MG; Colombo T; Bertello C; Pacciarini MA; Martini A
    Oncology; 1981; 38(1):53-8. PubMed ID: 7443177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the adriamycin-DNA complex in kidney allograft immunosuppression.
    Smeesters C; Giroux L; Trouet A; Jean G; Boury F; Corman J
    Can J Surg; 1981 Nov; 24(6):597-600. PubMed ID: 7034915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can neo-adjuvant chemotherapy prevent residual tumors?
    Bourut C; Chenu E; Mathé G
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():59-63. PubMed ID: 2977811
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative effect of three nucleosides on suppression of cancer growth in mice.
    Strong LC; Matsunaga H
    J Surg Oncol; 1973; 5(2):181-8. PubMed ID: 4703844
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of experimental mammary adenocarcinoma with herbicides.
    Bradley RL; Shoemaker JP; Hoffman RV
    Cancer Chemother Rep; 1974; 58(5 Pt 1):745-8. PubMed ID: 4138968
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes.
    Deprez-De Campeneere D; Baurain R; Huybrechts M; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):25-30. PubMed ID: 498415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
    Pacciarini MA; Barbieri B; Colombo T; Broggini M; Garattini S; Donelli MG
    Cancer Treat Rep; 1978 May; 62(5):791-800. PubMed ID: 657163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice.
    Teicher BA; Holden SA; Crawford JM
    Cancer; 1988 Jun; 61(11):2196-201. PubMed ID: 3365649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of RNA on tumor growth in mice of lines with and without the milk factor].
    Tomsons VP; Verevkina KN; Matienko NA
    Dokl Akad Nauk SSSR; 1977; 232(1):217-20. PubMed ID: 188616
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of abdominal transplanted mammary tumor on peritoneal fluid cytology in mice.
    Davis RH; Sackman JW; Kramer DL; Balin H
    Obstet Gynecol; 1975 Feb; 45(2):190-2. PubMed ID: 1118092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Distribution and chemotherapeutic activity of daunomycin and adriamycin in spontaneous mammary carcinoma of mice].
    Lenaz L; Di Fronzo G
    Tumori; 1972; 58(4):213-8. PubMed ID: 4645070
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors.
    Branunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1978 May; 62(5):727-36. PubMed ID: 657158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.